Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-128924
Filing Date
2024-11-19
Accepted
2024-11-19 18:40:08
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6877
  Complete submission text file 0000950170-24-128924.txt   9061
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Issuer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9922 JEFFERSON BOULEVARD CULVER CITY CA 90232
Business Address
SOON-SHIONG PATRICK (Reporting) CIK: 0001189020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39468 | Film No.: 241477744

Mailing Address 9922 JEFFERSON BOULEVARD CULVER CITY CA 90232
Business Address 310-836-6400
Nant Capital, LLC (Reporting) CIK: 0001675758 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39468 | Film No.: 241477745